+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

5G-enabled Medical Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 192 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716124
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The 5G-enabled medical devices market is propelling healthcare into a future defined by secure connectivity, operational agility, and innovative care delivery. Senior leaders can capitalize on these advancements to shape efficient, patient-centric environments and drive new models of engagement.

Market Snapshot: 5G-Enabled Medical Devices Transforming Growth Trajectories

The global 5G-enabled medical devices market demonstrates rapid expansion, with the market size advancing from USD 991.10 million in 2024 to USD 1.22 billion in 2025 and reaching a projected USD 5.38 billion by 2032. Driving this surge is a compound annual growth rate (CAGR) of 23.56%. Healthcare organizations are responding to escalating demand for secure and high-speed data transfer, which underpins the adoption of advanced diagnostics and remote monitoring capabilities. Transitioning infrastructure supports operational resilience and ensures future readiness for evolving digital and regulatory requirements in clinical settings.

Scope & Segmentation: Drivers and Innovations in the 5G-Enabled Medical Devices Market

This report offers actionable insight for senior decision-makers examining market transformation drivers and regional developments in the 5G-enabled medical devices sector. The analysis demonstrates how healthcare stakeholders are leveraging leading-edge connectivity and adapting solutions to diverse clinical needs.

  • Product Types: Diagnostic equipment such as imaging systems and point-of-care devices facilitate early disease identification, while monitoring tools—including cardiac, glucose, and respiratory devices—enable continuous patient data acquisition for proactive intervention. Therapeutic equipment, including infusion pumps and neurostimulators, provides targeted clinical support in multiple care environments.
  • Applications: Devices enable real-time asset tracking, support emergency medical responses, enhance remote patient oversight, and foster efficient healthcare supply chains. Integration with smart hospital systems leads to process innovation and improved patient engagement.
  • End Users: Hospitals, ambulatory surgical centers, clinics, homecare providers, and telehealth organizations implement 5G-enabled solutions, enhancing coordinated care across centralized institutions and distributed care settings.
  • Connectivity Types: Market offerings span non-standalone and standalone 5G networks, dedicated private network solutions, and deployment across both mmWave and sub-6 GHz spectrums, balancing security, scalability, and operational flexibility in clinical deployments.
  • Network Architectures: Hybrid, enterprise, public operator, and MVNO models deliver architectural versatility, aligning integration strategies and compliance objectives for various healthcare provider scenarios.
  • Components: Device ecosystems are built on core hardware such as sensors, antennas, and modules, supplemented by consulting, system integration, and lifecycle support services. Specialized software platforms streamline analytics, secure mobility, and device management.
  • Regions: Adoption and investment rates differ across the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Local healthcare infrastructure, regulatory frameworks, and timing of 5G deployment shape market dynamics in each region.
  • Company Coverage: Established multinational manufacturers and emerging market entrants drive progress in device interoperability and integrated design, enabling seamless connectivity and efficient clinical adoption.

Key Takeaways for Senior Decision-Makers

  • Adoption of 5G in medical devices accelerates clinical workflows, enabling more agile diagnostics and real-time patient monitoring across distributed care networks.
  • Employing private and hybrid network models enhances cybersecurity, supporting compliance and mitigating risk in the protection of sensitive patient and institutional data.
  • Open standards and modular system architectures position organizations to adapt rapidly to shifting regulatory mandates while optimizing capital expenditure for future technology adoption.
  • Collaboration with telecommunications and analytics partners extends telemedicine and chronic care services, bolstering outcomes as patient needs evolve globally.
  • Strategic go-to-market approaches must reflect national and regional infrastructure strengths, reimbursement models, and distinctive patient care requirements.
  • Comprehensive segmentation enables targeted investments that support both acute care imperatives and long-term, scalable service models.

Tariff Impact: Navigating Cost Structures and Supply Chain Resilience

Recent tariff adjustments, particularly in the United States, are altering cost structures and spurring manufacturers to adopt localized or nearshore supply chains. Emphasizing modular product design and reinforcing alliances with telecommunications partners enhances supply chain agility and helps minimize regulatory disruption. This response ensures continued innovation and reliable product availability under shifting trade conditions.

Methodology & Data Sources

This analysis incorporates direct interviews with healthcare executives, expert consultations, and an in-depth examination of industry and regulatory filings. A methodical approach to data triangulation substantiates the report’s actionable, credible insights for senior leadership decision-making.

Why This Report Matters

  • Enables healthcare leaders to strategically prioritize technology deployments and invest in scalable 5G-enabled solutions that elevate clinical and operational efficiency.
  • Equips organizations to proactively respond to complex regional regulations and evolving supply chain imperatives with tailored guidance.
  • Supports effective allocation of resources by aligning investment strategies with the distinct needs of both mature and emerging healthcare markets.

Conclusion

5G-enabled medical devices are reshaping how care is delivered and managed. This report equips senior leaders with the clarity and strategic direction required to improve operational performance and patient outcomes amid the ongoing digital transformation of healthcare.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of 5G connectivity in remote patient monitoring wearables for real-time data transmission
5.2. Deployment of 5G-enabled ultrasound probes to support high-definition mobile imaging in rural clinics
5.3. Adoption of network slicing for prioritizing critical patient data traffic in hospital 5G networks
5.4. Development of ultra-low latency 5G surgical robots to enable remote telesurgery with haptic feedback
5.5. Implementation of 5G-powered AI algorithms for predictive maintenance of in-hospital medical equipment
5.6. Integration of 5G-enabled telepharmacy solutions to support remote medication management in care homes
5.7. Use of 5G connectivity to stream continuous patient biometric data securely to cloud-based analytics platforms
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. 5G-enabled Medical Devices Market, by Product Type
8.1. Diagnostic Devices
8.1.1. Imaging Diagnostics
8.1.1.1. CT Scanners
8.1.1.2. MRI Scanners
8.1.1.3. Ultrasound Devices
8.1.2. Laboratory Diagnostics
8.1.2.1. Blood Analyzer
8.1.2.2. Urinalysis Analyzer
8.1.3. Point Of Care Diagnostics
8.2. Monitoring Devices
8.2.1. Cardiac Monitoring
8.2.1.1. Home Cardiac Monitoring
8.2.1.2. Hospital Cardiac Monitoring
8.2.2. Glucose Monitoring
8.2.2.1. Continuous Glucose Monitoring
8.2.2.2. Intermittent Glucose Monitoring
8.2.3. Respiratory Monitoring
8.2.3.1. Sleep Apnea Monitoring
8.2.3.2. Spirometry Monitoring
8.2.4. Vital Signs Monitoring
8.2.4.1. Blood Pressure Monitoring
8.2.4.2. Heart Rate Monitoring
8.2.4.3. Temperature Monitoring
8.3. Therapeutic Devices
8.3.1. Infusion Pumps
8.3.1.1. Insulin Infusion
8.3.1.2. Pain Management Infusion
8.3.2. Insulin Pumps
8.3.2.1. Patch Pumps
8.3.2.2. Tubed Pumps
8.3.3. Neurostimulators
8.3.3.1. Deep Brain Stimulators
8.3.3.2. Spinal Cord Stimulators
8.3.4. Respiratory Therapy Devices
8.3.4.1. CPAP Machines
8.3.4.2. Ventilators
9. 5G-enabled Medical Devices Market, by Application
9.1. Asset Tracking
9.1.1. Device Tracking
9.1.1.1. Equipment Positioning
9.1.1.2. Wearable Asset Tracking
9.1.2. Supply Chain Monitoring
9.1.2.1. Cold Chain Monitoring
9.1.2.2. Inventory Visibility
9.2. Emergency Response
9.2.1. Ambulance Services
9.2.1.1. Mobile Diagnostics
9.2.1.2. Prehospital Telehealth
9.2.2. Disaster Management
9.2.2.1. Field Hospital Enablement
9.2.2.2. Remote Coordination
9.3. Remote Patient Monitoring
9.3.1. Chronic Disease Management
9.3.1.1. Cardiac Care
9.3.1.2. Diabetes Management
9.3.2. Elderly Care
9.3.2.1. Activity Monitoring
9.3.2.2. Fall Detection
9.3.3. Postoperative Care
9.3.3.1. Pain Management
9.3.3.2. Wound Monitoring
9.4. Smart Hospital
9.4.1. Asset Management
9.4.1.1. Equipment Tracking
9.4.1.2. Inventory Management
9.4.2. Real-Time Location Services
9.4.2.1. Asset Tracking
9.4.2.2. Patient Tracking
9.4.3. Staff Management
9.4.3.1. Personnel Tracking
9.4.3.2. Workflow Optimization
9.5. Telemedicine
9.5.1. Emergency Teleconsultation
9.5.1.1. Ambulance Telehealth
9.5.1.2. Disaster Telecare
9.5.2. Video Consultation
9.5.2.1. AI-Assisted Diagnostics
9.5.2.2. Real-Time HD Video
9.5.3. Virtual ICU
9.5.3.1. Alarm Management
9.5.3.2. Remote Patient Surveillance
10. 5G-enabled Medical Devices Market, by End User
10.1. Ambulatory Surgical Centers
10.1.1. Hospital-Affiliated
10.1.2. Independent
10.2. Clinics
10.2.1. Outpatient Clinics
10.2.2. Specialty Clinics
10.3. Home Healthcare
10.3.1. Patient Homes
10.3.2. Senior Care Facilities
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Telehealth Providers
10.5.1. Platform Providers
10.5.2. Service Aggregators
11. 5G-enabled Medical Devices Market, by Connectivity Type
11.1. NonStandalone 5G
11.1.1. MmWave
11.1.2. Sub6GHz
11.2. Private 5G
11.2.1. Campus Network
11.2.2. Industrial Network
11.3. Standalone 5G
11.3.1. MmWave
11.3.2. Sub6GHz
12. 5G-enabled Medical Devices Market, by Network Architecture
12.1. Hybrid Network
12.1.1. Edge Integrated
12.1.2. On-Premise Core
12.2. Private Network
12.2.1. Campus Network
12.2.2. Enterprise Network
12.3. Public Network
12.3.1. MVNO
12.3.2. Operator Network
13. 5G-enabled Medical Devices Market, by Component
13.1. Hardware
13.1.1. Antennas
13.1.2. Modules
13.1.2.1. Connectivity Modules
13.1.2.2. Power Modules
13.1.3. Sensors
13.2. Services
13.2.1. Consulting Services
13.2.2. Integration Services
13.2.3. Maintenance Services
13.3. Software
13.3.1. Analytics Software
13.3.2. Mobility Applications
13.3.3. Platforms
14. 5G-enabled Medical Devices Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. 5G-enabled Medical Devices Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. 5G-enabled Medical Devices Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. General Electric Company
17.3.2. Siemens Healthineers AG
17.3.3. Koninklijke Philips N.V.
17.3.4. Medtronic plc
17.3.5. Johnson & Johnson
17.3.6. Abbott Laboratories
17.3.7. Becton, Dickinson and Company
17.3.8. Baxter International Inc.
17.3.9. Boston Scientific Corporation
17.3.10. Samsung Electronics Co., Ltd

Companies Mentioned

The companies profiled in this 5G-enabled Medical Devices market report include:
  • General Electric Company
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Samsung Electronics Co., Ltd

Table Information